{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:18:39Z","timestamp":1793056719407,"version":"4.5.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007394","name":"Association Laurette Fugain","doi-asserted-by":"publisher","award":["ALF2020\/05"],"award-info":[{"award-number":["ALF2020\/05"]}],"id":[{"id":"10.13039\/100007394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acute myeloid leukemia (AML) is a rare haematological cancer with poor 5-years overall survival (OS) and high relapse rate. Leukemic cells are sensitive to Natural Killer (NK) cell mediated killing. However, NK cells are highly impaired in AML, which promote AML immune escape from NK cell immune surveillance. We made the first report of CD56neg CD16+ NK cells expansion in AML. This unconventional subset has been reported to expand in some chronic viral infections. Although it is unclear whether CD56neg NK cells expansion mechanism is common across diseases, it seems more relevant than ever to further investigate this subset, representing a potential therapeutic target.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used PBMCs from AML patients and HV to perform mass cytometry, spectral flow cytometry, bulk RNA-seq and in vitro assays in order to better characterize CD56neg CD16+ NK cells that expand in AML.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We confirmed that CD56neg CD16+ NK cells represent a unique NK cell subset coexpressing Eomes and T-bet. CD56neg CD16+ NK cells could recover CD56 expression in vitro where they displayed unaltered NK cell functions. We previously demonstrated that CD56neg CD16+ NK cells expansion at diagnosis was associated with adverse clinical outcome in AML. Here, we validated our findings in a validation cohort of N=38 AML patients. AML patients with CD56neg CD16+ NK cells expansion at diagnosis had decreased overall survival (HR[CI95]=5.5[1.2-24.5], p=0.0251) and relapse-free survival (HR[CI95]=13.1[1.9-87.5], p=0.0079) compared to AML patients without expansion after 36 months follow-up. RNA-seq unveiled that CD56neg CD16+ NK cells were mature circulating NK cells with functional capacities. Upon expansion, CD56neg CD16+ NK cells from AML patients showed altered proteomic phenotype, with increased frequency of terminally mature CD56neg CD16+ NK cells expressing TIGIT along with decreased frequency of Siglec-7+ CD56neg CD16+ NK cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Taken together, our results suggest that we could harness CD56neg CD16+ NK cells cytotoxic potential in vitro to restore NK cell anti-tumor response in AML patients with CD56neg CD16+ NK cells expansion and improve patients\u2019 prognosis. To conclude, CD56neg CD16+ NK cells represent a relevant target for future NK-cell-based immunotherapies in AML.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1487792","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:14:52Z","timestamp":1736489692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML"],"prefix":"10.3389","volume":"15","author":[{"given":"Julia","family":"Wlosik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Orlanducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Richaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemence","family":"Demerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Ben","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Sarah","family":"Rouviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Livrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gorvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Hospital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dulphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raynier","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Vey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.12.001","article-title":"Natural killer cell education and the response to infection and cancer therapy: stay tuned","volume":"39","author":"Boudreau","year":"2018","journal-title":"Trends Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00162","article-title":"A new hope for CD56negCD16pos NK cells as unconventional cytotoxic mediators: an adaptation to chronic diseases","volume":"10","author":"Forconi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199511000-00005","article-title":"Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity","volume":"10","author":"Hu","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56\u2013\/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.811091","article-title":"Immune dysfunctions of CD56neg NK cells are associated with HIV-1 disease progression","volume":"12","author":"Cao","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901437","article-title":"Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment","volume":"183","author":"Gonzalez","year":"2009","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"eadd9012","DOI":"10.1126\/scitranslmed.add9012","article-title":"Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria","volume":"15","author":"Ty","year":"2023","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2020459118","DOI":"10.1073\/pnas.2020459118","article-title":"High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome","volume":"118","author":"Chretien","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112059","article-title":"NK cell defects: implication in acute myeloid leukemia","volume":"14","author":"D\u2019Silva","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.87","article-title":"Natural killer cell immune escape in acute myeloid leukemia","volume":"26","author":"Lion","year":"2012","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13045-020-00996-x","article-title":"Natural killer cell-based immunotherapy for acute myeloid leukemia","volume":"13","author":"Xu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e57346","DOI":"10.7554\/eLife.57346","article-title":"CD56 regulates human NK cell cytotoxicity through Pyk2","volume":"9","author":"Gunesch","year":"2020","journal-title":"Elife"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1038\/s41598-019-45377-8","article-title":"CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse","volume":"9","author":"Taouk","year":"2019","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01626-2","article-title":"Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123","volume":"41","author":"Gauthier","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s41467-017-01689-9","article-title":"Visual analysis of mass cytometry data by hierarchical stochastic neighbor embedding reveals rare cell types","volume":"8","author":"van Unen","year":"2017","journal-title":"Nat Commun"},{"key":"B17","unstructured":"T-BET and EOMES sustain mature human NK cell identity and antitumor function\n          \n          \n            \n              Wong\n              P\n            \n            \n              Foltz\n              JA\n            \n            \n              Chang\n              L\n            \n            \n              Neal\n              CC\n            \n            \n              Yao\n              T\n            \n            \n              Cubitt\n              CC\n            \n          \n          \n          2023"},{"key":"B18","doi-asserted-by":"publisher","first-page":"eaax9198","DOI":"10.1126\/science.aax9198","article-title":"A genome-wide transcriptomic analysis of protein-coding genes in human blood cells","volume":"366","author":"Uhlen","year":"2019","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01311-1","article-title":"Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress","volume":"23","author":"Montaldo","year":"2022","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"dev193854","DOI":"10.1242\/dev.193854","article-title":"A primer for generating and using transcriptome data and gene sets","volume":"147","author":"Cockrum","year":"2020","journal-title":"Dev (Cambridge England)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e202302069","DOI":"10.26508\/lsa.202302069","article-title":"Myc controls NK cell development, IL-15-driven expansion, and translational machinery","volume":"6","author":"Khameneh","year":"2023","journal-title":"Life Sci Alliance"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092176","article-title":"Nfil3\/E4bp4 is required for the development and maturation of NK cells in vivo","volume":"206","author":"Kamizono","year":"2009","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400534","article-title":"Notch signaling at later stages of Natural Killer cell development enhances KIR expression and functional maturation","volume":"193","author":"Felices","year":"2014","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.1.180.180","article-title":"Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-\u03b21 and independent accessory cell-derived contact and soluble factors","volume":"87","author":"Pierson","year":"1996","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0811413","article-title":"Kr\u00fcppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen","volume":"91","author":"Shik Park","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201202137","article-title":"INF2 promotes the formation of detyrosinated microtubules necessary for centrosome reorientation in T cells","volume":"198","author":"Andr\u00e9s-Delgado","year":"2012","journal-title":"J Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712182105","article-title":"ATF3 regulates MCMV infection in mice by modulating IFN-\u03b3 expression in natural killer cells","volume":"105","author":"Rosenberger","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01459","article-title":"Cystatin F affects natural killer cell cytotoxicity","volume":"8","author":"Peri\u0161i\u0107 Nanut","year":"2017","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e83913","DOI":"10.1371\/journal.pone.0083913","article-title":"CD86 is an activation receptor for NK cell cytotoxicity against tumor cells","volume":"8","author":"Peng","year":"2013","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1182\/blood-2023-182511","article-title":"G-CSFR is a checkpoint of natural killer cells against tumor","volume":"142","author":"Cao","year":"2023","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1038\/s41467-022-31626-4","article-title":"Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity","volume":"13","author":"Gilchrist","year":"2022","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.09.035","article-title":"Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma","volume":"194","author":"Zhang","year":"2015","journal-title":"J Surg Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.03.018","article-title":"Expression and regulation of complement receptors by human natural killer cells","volume":"219","author":"Min","year":"2014","journal-title":"Immunobiology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1079","article-title":"Expression of a functional c-kit receptor on a subset of natural killer cells","volume":"178","author":"Matos","year":"1993","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"eabc9801","DOI":"10.1126\/sciimmunol.abc9801","article-title":"The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation","volume":"6","author":"Holmes","year":"2021","journal-title":"Sci Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00535","article-title":"The transcription factor ZNF683\/HOBIT regulates human NK-cell development","volume":"8","author":"Post","year":"2017","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1065","DOI":"10.1002\/ctm2.v12.10","article-title":"Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma","volume":"12","author":"Li","year":"2022","journal-title":"Clin Trans Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100162","article-title":"Differential integrin adhesome expression defines human natural killer cell residency and developmental stage","volume":"207","author":"Hegewisch-Solloa","year":"2021","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00414","article-title":"Human NK cell subsets redistribution in pathological conditions: A role for CCR7 receptor","volume":"7","author":"Pesce","year":"2016","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e146686","DOI":"10.1172\/JCI146686","article-title":"Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues","volume":"131","author":"Ali","year":"","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02159\/full","article-title":"The role of CXC chemokine receptors 1\u20134 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.6.3669","article-title":"CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration","volume":"177","author":"Bernstein","year":"2006","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/sji.2016.84.issue-3","article-title":"Siglec-7 defines a highly functional natural killer cell subset and inhibits cell-mediated activities","volume":"84","author":"Shao","year":"2016","journal-title":"Scandinavian J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747450","article-title":"Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells","volume":"48","author":"Voigt","year":"2018","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747299","article-title":"T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1","volume":"48","author":"Zhang","year":"2018","journal-title":"Eur J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"19107","DOI":"10.1038\/s41598-023-46552-8","article-title":"Comprehensive characterization of TGFB1 across hematological Malignancies","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101774","article-title":"CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age","volume":"11","author":"M\u00fcller-Durovic","year":"2019","journal-title":"Aging (Albany NY)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1487792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:14:56Z","timestamp":1736489696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1487792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2024.1487792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1487792","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1487792"}}